Insider sale
TAYSHA GENE THERAPIES, INC.
$268.3K
56.88K shares
What this filing means
PORTER FRED plans to sell 56.88K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $268.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2026ACC: 0001979666-26-000006
56.88K
Shares to sell
$268.3K
Approx. market value
889.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
RSU Award
Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer.
2/3/2026
889.00Total acquired889.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/3/2026 | RSU Award Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer. | 889.00 | — |
| Total | 889.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
12.99K
Market value
$59.9K
1/26/2026
—Completed
Units to sell
43K
Market value
$204.3K
1/23/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
889.00
Market value
$4.2K
2/4/2026
Total
Units
56.88K
Value
$268.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/26/2026 | 12.99K | $59.9K | — | Completed |
1/23/2026 | 43K | $204.3K | — | Completed |
| Planned — Approximate Date | ||||
2/4/2026 | 889.00 | $4.2K | Nasdaq | Planned |
| Total | 56.88K | $268.3K | ||